- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07419503
010Fit'R - Healthy Lifestyle Interventions for Children With Overweight (010Fit'R)
010 Fit'R 2025-2027: Approach for Children (4-12 Years Old) With Overweight
Overweight is a leading risk factor for non-communicable diseases. In the Netherlands, about 11% of children aged 4-12 years are overweight. The causes of childhood overweight are multifaceted, involving (epi)genetic, environmental, socioeconomic, and behavioral factors. The societal consequences are far-reaching, including lower academic performance, reduced quality of life and a greater risk of developing obesity in adulthood.
Lifestyle interventions with diet and physical activity components have been shown to effectively reduce childhood overweight. The "010 Fit'R - Rotterdam approach for children with overweight" targets children between 4 and 12 years old and their parents. The program consists of multicomponent interventions addressing various lifestyle aspects, such as physical activity, nutrition, motor skills and healthy behaviours aiming to foster sustainable lifestyle changes. Providers were invited by the municipality of Rotterdam to develop interventions within the policy framework of 010 Fit'R. 12 providers were selected by the municipality based on the selection criteria (quality of the program; experience with the activities and target group; demonstrable connection with the area; connection with the target group; recruitment strategy; costs) and distributed over different neighbourhoods. This study evaluates the healthy lifestyle interventions involved in 010 Fit'R in terms of effectiveness and implementation outcomes.
Quantitative data includes self-reported questionnaires, administrative data, a motor skill performance assessment and height and weight measurements to determine Body Mass Index (BMI). Data will be collected through self-reported questionnaires filled in by the parents of children who participate in 010 Fit'R. Additionally, children will be assessed on motor skills by providers of healthy lifestyle interventions involved in 010 Fit'R. Moreover, weight and height will be measured by the provider following standardized procedures. The parental questionnaire, motor skills and BMI will be assessed pre and post intervention. Administrative data includes data reported by providers on implementation outcomes, for example, data regarding enrolment and retention.
Qualitative data includes documentary evidence of each healthy lifestyle intervention involved in 010 Fit'R to assess 'effective components' of interventions. In addition, two workshops with providers and/or practitioners of interventions will be held to map the context, working elements and outcomes.
Focus groups (FGs) and semi-structured interviews are used to gather information from parents, children and providers and/or practitioners regarding implementation outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Holland
-
Rotterdam, South Holland, Netherlands, 3015GD
- Department of Public Health, Erasmus MC University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Providers of the interventions will recruite children (4-12 years old) with overweight to participate in their intervention. All children (and their parents) participating in the interventions are invited to participate in the evaluation research study.
Inclusion Criteria:
- Child participates in the 010Fit'R program and is between 4 and 12 years old (at the start of recruitment)
- Parents of children participating in the 010 Fit'R program
- Provider (e.g. participate in interview) is actively involved in promoting, implementing or conducting a healthy lifestyle intervention funded by 010Fit'R
All participants should be able to comprehend provided information to make an informed decision for participation and should provide consent for participating. In case of children the parent(s) consent, as well as the child when 12 years old.
Exclusion Criteria:
- Outside of the age range, no consent for participation from provider, parent and/or child
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Lifestyle intervention
Children (4-12 years old) participate in one of 12 healthy lifestyle interventions focused on physical activity, nutrition and additional lifestyle factors
|
Within the policy framework of 010 Fit'R, 12 different healthy lifestyle interventions will be implemented for children with overweight.
Children participate in one of the 12 interventions.
All interventions consist of at least one physical activity each week and encouraging a healthy lifestyle in children, individually or in groups, and advising children and their parents on nutrition, exercise, motor skills, and sustainable behavioral change.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PROMIS - assessed by a questionnaire
Time Frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
Health-related quality of life measured by the Patient-Reported Outcomes Measurement Information System
|
Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BMI - assessed by physical measurement
Time Frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
Based on height and weight
|
Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
|
Motor skills - assessed by physical measurement
Time Frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
4 S-en test (Kernebeek et al., 2018)
|
Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
|
Nutrition - assessed by a questionnaire
Time Frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
Frequency of eating breakfast, fruit, vegetables, whole grain producents, sweet beverages, snacks
|
Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
|
Physical activity - assessed by a questionnaire
Time Frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
Frequency and duration of playing sports, playing outside, perception of physical behaviour
|
Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
|
Sleep behaviour - assessed by a questionnaire
Time Frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
General duration of sleep (hours) and sleep behaviour in the past 2 months
|
Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
|
Screen time - assessed by a questionnaire
Time Frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
General duration of screen time (hours) on weekdays and during weekends
|
Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Demographic variables - assessed by a questionnaire
Time Frame: Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
Age, gender, living situation, country of birth, income and education level of parents
|
Pre- and post intervention - from enrollment to the end of intervention (depending on intervention at 12 to 40 weeks)
|
|
Feasibility data on implementation outcomes
Time Frame: At the end of an intervention (depending on intervention at 12 to 40 weeks)
|
Feasibility data on implementation outcomes (e.g.
reach, adoption, implementation, sustainability) will be collected through questionnaires for parents, focus groups with children and parents, administrative data and interviews with providers
|
At the end of an intervention (depending on intervention at 12 to 40 weeks)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13555
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
Carmen Lucas AbellánUniversidad Católica San Antonio de MurciaCompletedOverweight/Obesity | Overweight or Obese | Overweight or Obese Adults | Obesity and Overweight | Obese SubjectsSpain
-
Children's Hospital Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight AdolescentsUnited States
-
University Hospital Bispebjerg and FrederiksbergUniversity of CopenhagenCompleted
-
Empros Pharma ABNot yet recruitingOverweight or Obese | Obesity and Overweight
-
University of AarhusThe Danish Dairy Research Foundation, Denmark; Sygekassernes HelsefondCompletedOverweight and Obesity | Overweight Adolescents | Metabolic DiseaseDenmark
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight, Childhood | Overweight, InfantFrance
-
Medialis Ltd.RecruitingObesity & Overweight | Overweight (BMI > 25)United Kingdom
-
Federal University of Health Science of Porto AlegreCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.Active, not recruitingObesity & Overweight | Overweight (BMI > 25)Brazil
-
National Taiwan University HospitalCompleted
Clinical Trials on 010 Fit'R intervention
-
Contera PharmaBukwang PharmaceuticalCompletedDyskinesiasFrance, Germany, Italy, Korea, Republic of, Spain
-
Tianjin Chasesun Pharmaceutical Co., LTDEnrolling by invitation
-
Synthetic Biologics Inc.CompletedIrritable Bowel Syndrome With Constipation (IBS-C)United States
-
MallinckrodtTerminatedAdvanced Solid TumorsUnited States
-
Synthetic Biologics Inc.CompletedIrritable Bowel Syndrome With Constipation (IBS-C)United States
-
BioMimetix JV, LLCTerminatedAcne VulgarisUnited States
-
BioMimetix JV, LLCCompletedPsoriasis | Atopic DermatitisUnited States
-
Orca Therapeutics B.V.CMX ResearchActive, not recruitingAdenocarcinoma of the ProstateCanada
-
BioMimetix JV, LLCSuspended
-
Guangzhou Gloria Biosciences Co., Ltd.Not yet recruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma | Classic Hodgkin's Lymphoma